Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1994 1
1995 1
1997 4
1998 4
1999 4
2000 2
2001 11
2002 13
2003 8
2004 10
2005 8
2006 12
2007 21
2008 15
2009 18
2010 15
2011 15
2012 10
2013 13
2014 16
2015 12
2016 20
2017 14
2018 8
2019 12
2020 15
2021 21
2022 20
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

301 results

Results by year

Filters applied: . Clear all
Page 1
Editorial: Complement and COVID-19 Disease.
Prohászka Z, Merle NS. Prohászka Z, et al. Front Immunol. 2022 Jul 1;13:960809. doi: 10.3389/fimmu.2022.960809. eCollection 2022. Front Immunol. 2022. PMID: 35844521 Free PMC article. No abstract available.
Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura.
De Waele L, Sakai K, Mancini I, Sinkovits G, Falter T, Inoue T, Agosti P, Rossmann H, Von Auer C, Tersteeg C, De Meyer SF, Joly BS, Veyradier A, Coppo P, Fijnheer R, Peyvandi F, Prohászka Z, Lämmle B, Vanhoorelbeke K. De Waele L, et al. Among authors: prohaszka z. J Thromb Haemost. 2024 Feb;22(2):493-502. doi: 10.1016/j.jtha.2023.10.014. Epub 2023 Oct 20. J Thromb Haemost. 2024. PMID: 37866519
Immunosuppressive Therapy of Antibody-Mediated aHUS and TTP.
Kelen K, Horváth O, Kis É, Mikes B, Sallay P, Prohászka Z, Szabó AJ, Reusz GS. Kelen K, et al. Among authors: prohaszka z. Int J Mol Sci. 2023 Sep 21;24(18):14389. doi: 10.3390/ijms241814389. Int J Mol Sci. 2023. PMID: 37762692 Free PMC article.
Expanding Horizons in Complement Analysis and Quality Control.
Frazer-Abel A, Kirschfink M, Prohászka Z. Frazer-Abel A, et al. Among authors: prohaszka z. Front Immunol. 2021 Aug 9;12:697313. doi: 10.3389/fimmu.2021.697313. eCollection 2021. Front Immunol. 2021. PMID: 34434189 Free PMC article. Review.
The role of the complement system in hereditary angioedema.
Csuka D, Veszeli N, Varga L, Prohászka Z, Farkas H. Csuka D, et al. Among authors: prohaszka z. Mol Immunol. 2017 Sep;89:59-68. doi: 10.1016/j.molimm.2017.05.020. Epub 2017 Jun 7. Mol Immunol. 2017. PMID: 28595743 Review.
Complement analysis in the era of targeted therapeutics.
Prohászka Z, Kirschfink M, Frazer-Abel A. Prohászka Z, et al. Mol Immunol. 2018 Oct;102:84-88. doi: 10.1016/j.molimm.2018.06.001. Epub 2018 Jun 20. Mol Immunol. 2018. PMID: 29933889 Review.
Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups.
Hurler L, Szilágyi Á, Mescia F, Bergamaschi L, Mező B, Sinkovits G, Réti M, Müller V, Iványi Z, Gál J, Gopcsa L, Reményi P, Szathmáry B, Lakatos B, Szlávik J, Bobek I, Prohászka ZZ, Förhécz Z, Csuka D, Kajdácsi E, Cervenak L, Kiszel P, Masszi T, Vályi-Nagy I, Würzner R; Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration; Lyons PA, Toonen EJM, Prohászka Z. Hurler L, et al. Among authors: prohaszka z, prohaszka zz. Front Immunol. 2023 Mar 27;14:1162171. doi: 10.3389/fimmu.2023.1162171. eCollection 2023. Front Immunol. 2023. PMID: 37051252 Free PMC article.
301 results